|
1
|
Sims JE, Nicklin MJ, Bazan JF, Barton JL,
Busfield SJ, Ford JE, Kastelein RA, Kumar S, Lin H, Mulero JJ, et
al: A new nomenclature for IL-1-family genes. Trends Immunol.
22:536–537. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dinarello C, Arend W, Sims J, Smith D,
Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H,
Bufler P, et al: IL-1 family nomenclature. Nat Immunol. 11:9732010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharaf N, Nicklin MJ and di Giovine FS:
Long-range DNA interactions at the IL-1/IL-36/IL-37 gene cluster
(2q13) are induced by activation of monocytes. Cytokine. 68:16–22.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mulero JJ, Pace AM, Nelken ST, Loeb DB,
Correa TR, Drmanac R and Ford JE: IL1HY1: A novel interleukin-1
receptor antagonist gene. Biochem Biophys Res Commun. 263:702–706.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Towne JE, Renshaw BR, Douangpanya J,
Lipsky BP, Shen M, Gabel CA and Sims JE: Interleukin-36 (IL-36)
ligands require processing for full agonist (IL-36α, IL-36β and
IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem.
286:42594–42602. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Costelloe C, Watson M, Murphy A, McQuillan
K, Loscher C, Armstrong ME, Garlanda C, Mantovani A, O'Neill LA,
Mills KH and Lynch MA: IL-1F5 mediates anti-inflammatory activity
in the brain through induction of IL-4 following interaction with
SIGIRR/TIR8. J Neurochem. 105:1960–1969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gresnigt MS and van de Veerdonk FL:
Biology of IL-36 cytokines and their role in disease. Semin
Immunol. 25:458–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Wang Y, Bai C and Wang X:
Alterations of plasma inflammatory biomarkers in the healthy and
chronic obstructive pulmonary disease patients with or without
acute exacerbation. J Proteomics. 75:2835–2843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramadas RA, Li X, Shubitowski DM, Samineni
S, Wills-Karp M and Ewart SL: IL-1 Receptor antagonist as a
positional candidate gene in a murine model of allergic asthma.
Immunogenetics. 58:851–855. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Asseldonk EJ, Stienstra R, Koenen TB,
van Tits LJ, Joosten LA, Tack CJ and Netea MG: The effect of the
interleukin-1 cytokine family members IL-1F6 and IL-1F8 on
adipocyte differentiation. Obesity (Silver Spring). 18:2234–2236.
2010. View Article : Google Scholar
|
|
11
|
Kim TJ, Kim TH, Lee HJ, Peddle L, Rahman
P, Hu P, Greenwood CM and Inman RD: Interleukin 1 polymorphisms in
patients with ankylosing spondylitis in Korea. J Rheumatol.
35:1603–1608. 2008.PubMed/NCBI
|
|
12
|
Frey S, Derer A, Messbacher ME, Baeten DL,
Bugatti S, Montecucco C, Schett G and Hueber AJ: The novel cytokine
interleukin-36α is expressed in psoriatic and rheumatoid arthritis
synovium. Ann Rheum Dis. 72:1569–1574. 2013. View Article : Google Scholar
|
|
13
|
Mattii M, Ayala F, Balato N, Filotico R,
Lembo S, Schiattarella M, Patruno C, Marone G and Balato A: The
balance between pro-and anti-inflammatory cytokines is crucial in
human allergic contact dermatitis pathogenesis: The role of IL-1
family members. Exp Dermatol. 22:813–819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heinemann A, He Y, Zimina E, Boerries M,
Busch H, Chmel N, Kurz T, Bruckner-Tuderman L and Has C: Induction
of phenotype modifying cytokines by FERMT1 mutations. Hum Mutat.
32:397–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karumbaiah L, Norman SE, Rajan NB, Anand
S, Saxena T, Betancur M, Patkar R and Bellamkonda RV: The
upregulation of specific interleukin (IL) receptor antagonists and
paradoxical enhancement of neuronal apoptosis due to electrode
induced strain and brain micromotion. Biomaterials. 33:5983–5996.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Towne JE and Sims JE: IL-36 in psoriasis.
Curr Opin Pharmacol. 12:486–490. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marrakchi S, Guigue P, Renshaw BR, Puel A,
Pei XY, Fraitag S, Zribi J, Bal E, Cluzeau C, Chrabieh M, et al:
Interleukin-36-receptor antagonist deficiency and generalized
pustular psoriasis. N Engl J Med. 365:620–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugiura K, Takeichi T, Kono M, Ogawa Y,
Shimoyama Y, Muro Y and Akiyama M: A novel IL36RN/IL1F5 homozygous
nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset
generalized pustular psoriasis. Br J Dermatol. 167:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Onoufriadis A, Simpson MA, Pink AE, Di
Meglio P, Smith CH, Pullabhatla V, Knight J, Spain SL, Nestle FO,
Burden AD, et al: Mutations in IL36RN/IL1F5 are associated with the
severe episodic inflammatory skin disease known as generalized
pustular psoriasis. Am J Hum Genet. 89:432–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanazawa N, Nakamura T, Mikita N and
Furukawa F: Novel IL36RN mutation in a Japanese case of early onset
generalized pustular psoriasis. J Dermatol. 40:749–751. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar S, Nei M, Dudley J and Tamura K:
MEGA: A biologist-centric software for evolutionary analysis of DNA
and protein sequences. Brief Bioinform. 9:299–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Z, Nielsen R, Goldman N and Pedersen
AM: Codon-substitution models for heterogeneous selection pressure
at amino acid sites. Genetics. 155:431–449. 2000.PubMed/NCBI
|
|
23
|
Yang Z: PAML 4: Phylogenetic analysis by
maximum likelihood. Mol Biol Evol. 24:1586–1591. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Chen K, Xu W, Chen D, Tang W and
Xia TS: Integrative genomic analyses of secreted protein acidic and
rich in cysteine and its role in cancer prediction. Mol Med Rep.
10:1461–1468. 2014.PubMed/NCBI
|
|
25
|
Kolker E, Higdon R, Morgan P, Sedensky M,
Welch D, Bauman A, Stewart E, Haynes W, Broomall W and Kolker N:
SPIRE: Systematic protein investigative research environment. J
Proteomics. 75:122–126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kolker E, Higdon R, Haynes W, Welch D,
Broomall W, Lancet D, Stanberry L and Kolker N: MOPED: Model
organism protein expression database. Nucleic Acids Res.
40:D1093–D1099. 2012. View Article : Google Scholar :
|
|
27
|
Wang B, Xu W, Tan M, Xiao Y, Yang H and
Xia TS: Integrative genomic analyses of a novel cytokine,
interleukin-34 and its potential role in cancer prediction. Int J
Mol Med. 35:92–102. 2015.
|
|
28
|
Wang M, Wei X, Shi L, Chen B, Zhao G and
Yang H: Integrative genomic analyses of the histamine H1 receptor
and its role in cancer prediction. Int J Mol Med. 33:1019–1026.
2014.PubMed/NCBI
|
|
29
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the catalogue of somatic
mutations in cancer. Nucleic Acids Res. 39:D945–D950. 2011.
View Article : Google Scholar :
|
|
30
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sugiura K, Takemoto A, Yamaguchi M,
Takahashi H, Shoda Y, Mitsuma T, Tsuda K, Nishida E, Togawa Y,
Nakajima K, et al: The majority of generalized pustular psoriasis
without psoriasis vulgaris is caused by deficiency of
interleukin-36 receptor antagonist. J Invest Dermatol.
133:2514–2521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS,
Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, et al: Predictive value
of progression-related gene classifier in primary non-muscle
invasive bladder cancer. Mol Cancer. 9:32010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bos PD, Zhang XH, Nadal C, Shu W, Gomis
RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA and
Massagué J: Genes that mediate breast cancer metastasis to the
brain. Nature. 459:1005–1009. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar
|
|
35
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar
|
|
36
|
Yoshihara K, Tajima A, Yahata T, Kodama S,
Fujiwara H, Suzuki M, Onishi Y, Hatae M, Sueyoshi K, Fujiwara H, et
al: Gene expression profile for predicting survival in
advanced-stage serous ovarian cancer across two independent
datasets. PLoS One. 5:e96152010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kappelmann M, Bosserhoff A and Kuphal S:
AP-1/c-Jun transcription factors: Regulation and function in
malignant melanoma. Eur J Cell Biol. 93:76–81. 2014. View Article : Google Scholar
|
|
39
|
Karamouzis MV, Konstantinopoulos PA and
Papavassiliou AG: The activator protein-1 transcription factor in
respiratory epithelium carcinogenesis. Mol Cancer Res. 5:109–120.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Caputto BL, Cardozo Gizzi AM and Gil GA:
C-Fos: an AP-1 transcription factor with an additional cytoplasmic,
non-genomic lipid synthesis activation capacity. Biochim Biophys
Acta. 1841:1241–1246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Milde-Langosch K: The Fos family of
transcription factors and their role in tumourigenesis. Eur J
Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Motrich RD, Castro GM and Caputto BL: Old
players with a newly defined function: Fra-1 and c-Fos support
growth of human malignant breast tumors by activating membrane
biogenesis at the cytoplasm. PLoS One. 8:e532112013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bakiri L, Lallemand D, Bossy-Wetzel E and
Yaniv M: Cell cycle-dependent variations in c-Jun and JunB
phosphorylation: A role in the control of cyclin D1 expression.
EMBO J. 19:2056–2068. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zenz R, Scheuch H, Martin P, Frank C,
Eferl R, Kenner L, Sibilia M and Wagner EF: C-Jun regulates eyelid
closure and skin tumor development through EGFR signaling. Dev
Cell. 4:879–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mils V, Piette J, Barette C, Veyrune J,
Tesnière A, Escot C, Guilhou JJ and Basset-Séguin N: The
proto-oncogene c-fos increases the sensitivity of keratinocytes to
apoptosis. Oncogene. 14:1555–1561. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schreiber M, Kolbus A, Piu F, Szabowski
kA, Möhle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF:
Control of cell cycle progression by c-Jun is p53 dependent. Genes
Dev. 13:607–619. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen F and Castranova V: Nuclear
factor-kappaB, an unappreciated tumor suppressor. Cancer Res.
67:11093–11098. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Horst D, Budczies J, Brabletz T, Kirchner
T and Hlubek F: Invasion associated up-regulation of nuclear factor
kappaB target genes in colorectal cancer. Cancer. 115:4946–4958.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zubair A and Frieri M: Role of nuclear
factor-kB in breast and colorectal cancer. Curr Allergy Asthma Rep.
13:44–49. 2013. View Article : Google Scholar
|
|
50
|
Yu LL, Yu HG, Yu JP, Luo HS, Xu XM and Li
JH: Nuclear factor-kappaB p65 (RelA) transcription factor is
constitutively activated in human colorectal carcinoma tissue.
World J Gastroenterol. 10:3255–3260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Vainer GW, Pikarsky E and Ben-Neriah Y:
Contradictory functions of NF-kappaB in liver physiology and
cancer. Cancer Lett. 267:182–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Arsura M and Cavin LG: Nuclear
factor-kappaB and liver carcinogenesis. Cancer Lett. 229:157–169.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
